BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9723765)

  • 21. Mechanical responses to two-tone distortion products in the apical and basal turns of the mammalian cochlea.
    Cooper NP; Rhode WS
    J Neurophysiol; 1997 Jul; 78(1):261-70. PubMed ID: 9242278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distortion product otoacoustic emissions: comparison of sequential versus simultaneous presentation of primary-tone pairs.
    Beattie RC
    J Am Acad Audiol; 2003 Nov; 14(9):471-84. PubMed ID: 14708836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters to maximize 2f2-f1 distortion product otoacoustic emission levels.
    Horn JH; Pratt SR; Durrant JD
    J Speech Lang Hear Res; 2008 Dec; 51(6):1620-9. PubMed ID: 18664689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The level and growth behavior of the 2 f1-f2 distortion product otoacoustic emission and its relationship to auditory sensitivity in normal hearing and cochlear hearing loss.
    Kummer P; Janssen T; Arnold W
    J Acoust Soc Am; 1998 Jun; 103(6):3431-44. PubMed ID: 9637030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of furosemide on distortion product otoacoustic emissions and on neuronal responses in the anteroventral cochlear nucleus.
    Rübsamen R; Mills DM; Rubel EW
    J Neurophysiol; 1995 Oct; 74(4):1628-38. PubMed ID: 8989399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of the 2f1-f2 otoacoustic emission in humans.
    Harris FP; Probst R; Xu L
    Hear Res; 1992 Dec; 64(1):133-41. PubMed ID: 1490896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate and short-term reliability of distortion-product otoacoustic emissions.
    Beattie RC; Kenworthy OT; Luna CA
    Int J Audiol; 2003 Sep; 42(6):348-54. PubMed ID: 14570243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards understanding the limits of distortion product otoacoustic emission measurements.
    Gorga MP; Neely ST; Bergman BM; Beauchaine KL; Kaminski JR; Liu Z
    J Acoust Soc Am; 1994 Sep; 96(3):1494-500. PubMed ID: 7963014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring Optimal Stimulus Frequency Ratio for Measurement of the Quadratic f2-f1 Distortion Product Otoacoustic Emission in Humans.
    Baiduc RR; Dhar S
    J Speech Lang Hear Res; 2018 Jul; 61(7):1794-1806. PubMed ID: 29946695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Otoacoustic distortion products in adults with normal hearing].
    Simoncelli C; Molini E; Ricci G; Capolunghi B; Alunni N
    Acta Otorhinolaryngol Ital; 1995 Apr; 15(2):80-6. PubMed ID: 8928654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of aging on medial olivocochlear system function.
    Lisowska G; Namyslowski G; Orecka B; Misiolek M
    Clin Interv Aging; 2014; 9():901-14. PubMed ID: 24959071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
    Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
    Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of Minor Conductive Hearing Loss in Humans Using Distortion Product Otoacoustic Emissions.
    Marcrum SC; Kummer P; Steffens T
    Ear Hear; 2017; 38(4):391-398. PubMed ID: 28169838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABR and DPOAE detection of cochlear damage by gentamicin.
    Shi Y; Martin WH
    J Basic Clin Physiol Pharmacol; 1997; 8(3):141-55. PubMed ID: 9429983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sample size on the reliability of noise floor and DPOAE.
    Beattie RC; Bleech J
    Br J Audiol; 2000 Oct; 34(5):305-9. PubMed ID: 11081755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distortion product otoacoustic emissions in infants from birth to two months].
    Pinto VS; Lewis DR
    Pro Fono; 2007; 19(2):195-204. PubMed ID: 17710346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Frequency Distortion-Product Otoacoustic Emission Repeatability in a Patient Population.
    Dreisbach L; Zettner E; Chang Liu M; Meuel Fernhoff C; MacPhee I; Boothroyd A
    Ear Hear; 2018; 39(1):85-100. PubMed ID: 28678077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency responses of two- and three-tone distortion product otoacoustic emissions in Mongolian gerbils.
    Mills DM
    J Acoust Soc Am; 2000 May; 107(5 Pt 1):2586-602. PubMed ID: 10830382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.